Direct-to-Consumer Genetic Testing Market is Estimated to reach US$ 4843.4 Million; Growing at CAGR of 11.4% by forecast 2033 end | Future Market Insights, Inc.

The Direct-to-Consumer Genetic Testing market is anticipated to witness significant demand primarily driven by ancestry tests, which comprise a major segment of genetic tests marketed directly to consumers (DTC-GT). These tests are directly sold to individuals without the involvement of healthcare professionals or health insurers.

NEWARK, Del, July 10, 2023 (GLOBE NEWSWIRE) -- The global Direct-To-Consumer Genetic Testing Market in 2022 was US$ 1,485.1 million and is estimated to be US$ 1645.5 million in 2023. Future Market Insights has mentioned in its reports that the smart agriculture solution market will expand at a CAGR of 11.40% between 2023 and 2033, totaling around US$ 4,843.4 million by 2033.

Boost in the income level in the advancing countries has further anticipated propelling the growth of the direct-to-consumer (DTC) genetic testing market where the rise in the cost of DTC genetic testing is further projected for uplifting the growth of the direct-to-consumer (DTC) genetic testing market in the timeline period.

Grab You’re Exclusive Report: Unveiling the Spectacular Growth of the Direct-to-Consumer Genetic Testing Market:

Key Takeaways from this Market:

  • The global direct-to-consumer genetic testing market is expected to grow at a CAGR of 11.2% from 2022 to 2032 and is likely to reach US$ 4.0 Billion in 2032.
  • The global direct-to-consumer genetic testing (DTC-GT) market grew at a CAGR of 9.8% between 2017 and 2022.
  • Direct-to-consumer genetic testing (DTC-GT) market grew at a CAGR of 15.6% and held about US$ 8.0 Billion of the global genetic testing market in 2021.
  • North America holds a major portion of the market with a value share of 48.2%.
  • The United States holds a direct-to-consumer genetic testing market share of about 42.9%.
  • Japan is said to hold an important part of the market with a value share of 6.3%.
  • China market is said to grow at a CAGR of 12.7% in East Asia.
  • India uses genetic screening services growing at a CAGR of 15.3%.
  • The Australian market is expected to expand at a CAGR of 8.9%.
  • Germany is set to exhibit a CAGR of nearly 7.1% in Europe where it holds 32.7% of the market share.
  • United Kingdom is likely to grow at a CAGR of 11.8%.
  • Ancestry tests segment exhibited high growth at a CAGR of 10.9%, with a projected share of about 38.2% in the global market in the same year.
  • The single nucleotide polymorphism chips segment held a market share of around 64.5% and is expected to showcase gradual growth over the forecast period.
  • The saliva segment held a direct-to-consumer genetic testing market share of 67.0%.
  • The retail sales segment held the highest direct-to-consumer genetic testing market share of nearly 79.5%.

“Usage of genetic marketers for affirming the existence of kinship relationships acts as one of the major opportunities in direct-to-consumer genetic testing manufacturers,” - comments an Analyst at Future Market Insights (FMI).

Our analyst is available to help you with any inquiries you may have:

Competitive Landscape:

Some of the prominent players in the global market are:

  • 23andMe
  • Ancestry DNA
  • Color Genomics, Inc.
  • Genetic Technology (EasyDNA)
  • Full Genomes Corporation, Inc.
  • Helix OpCo LLC
  • IDENTIGENE, LLC/ DNA Diagnostics Center
  • Living DNA Ltd
  • MyHeritage Ltd
  • Prenetics Limited
  • Family Tree DNA
  • Interleukin Genetics/orig3n
  • Counsyl/Myriad Genetics, Inc.
  • Veritas Genetics
  • Fulgent Genomics

Some of the recent industry developments in the global direct-to-consumer genetic testing market are:

  • In May 2023, 23andMe offers a trove of information about your genetics and deeper ancestry where this top DNA testing service also provides checks for genetic health risks and your carrier status for many conditions.

More Valuable Insights Available:

Future Market Insights offers an unbiased analysis of the direct-to-consumer genetic testing market providing historical data for 2017 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the direct-to-consumer genetic testing market is segmented based on major by By Product: (Pharmacogenetics Tests, Carrier Screening Tests, Genetic Health Risk (GHR) Tests, Cancer Predisposition Tests, Low-Risk General Wellness Tests, Ancestry Tests), By Technology: (Single Nucleotide Polymorphism Chip, Whole Genome Sequencing), By Sample: (Saliva, Urine, Blood), By Sales Channel: [(Institutional Sales- Hospitals, Specialty Clinics, Diagnostic Laboratories, Others), (Retail Sales- Retail Pharmacies, Online Sales)], By Region: (North America, Latin America, Europe, South Asia, East Asia, Oceania, The Middle East and Africa)

Fine-Tune Your Strategy: Request Customized Analysis to Stay Ahead in the Direct-to-Consumer Genetic Testing Market:

Market Outlook by Categorization:

By Product:

  • Pharmacogenetics Tests
  • Carrier Screening Tests
  • Genetic Health Risk (GHR) Tests
  • Cancer Predisposition Tests
  • Low-Risk General Wellness Tests
  • Ancestry Tests

By Technology:

  • Single Nucleotide Polymorphism Chip
  • Whole Genome Sequencing

By Sample:

  • Saliva
  • Urine
  • Blood

By Sales Channel:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
    • Diagnostic Laboratories
    • Others
  • Retail Sales
    • Retail Pharmacies
    • Online Sales

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • Middle East and Africa

Seize this Opportunity for Detailed Market Intel: Purchase Now to Access:

About the Healthcare Division at Future Market Insights (FMI):

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Explore FMI’s related ongoing Coverage on Healthcare Market Domain:

Osteotomy Plates Market Size: The osteotomy plates market is forecasted to be appraised at US$ 615.5 million by 2033, up from US$ 375.5 million in 2023, advancing at a CAGR of 5.1% during the forecast period.

Osteonecrosis Treatment Market Share: The osteonecrosis treatment market size is projected to be valued at US$ 268.2 million in 2023 and is expected to rise to US$ 434.0 million by 2033. 

Neuro Immunoassay Market Trends: The neuro immunoassay market is projected to be valued at US$ 5,303.1 million by 2033, up from US$ 2,616.1 million in 2023, increasing at a CAGR of 7.3% during the forecast period.

Veterinary Computed Tomography Scanner Market Growth: The veterinary computed tomography scanner market is currently valued at US$ 173.7 million in 2022 growing at a steady CAGR of 6.8% through 2033. The market is anticipated to cross the revenue value of US$ 355.3 million by 2033.

Veterinary Orthotics-Prosthetics Market Demand: According to the latest report published by Future Market Insights (FMI), the veterinary orthotics-prosthetics market size is predicted to surpass US$ 66.5 million in 2023. The veterinary orthotics-prosthetics market is projected to reach US$ 164.2 million in 2033 and is anticipated to thrive at a CAGR of 9.5% 

Veterinary Glucometers Market Opportunity: The veterinary glucometers market size is projected to be valued at US$ 351.3 million in 2023 and is expected to rise to US$ 574.9 million by 2033. The sales of veterinary glucometers are predicted to expand at a significant CAGR of 5.0% during the forecast period.

Visual Electrophysiology Market Overview: The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033. The market is expected to hold a market share of US$ 458.9 million by 2033 while the market is likely to reach a value of US$ 234.1 million in 2023.

Portable Anesthesia Systems Market Strategies: The global portable anesthesia systems market is expected to accumulate US$ 493.6 million in value by 2023 end. During the forecast period from 2023 to 2033, a CAGR of 6.6% has been projected for the market, with an expected closing value worth US$ 933.4 million.

SPECT Scanning Services Market Forecast: The global SPECT scanning services market is estimated to secure a valuation of US$ 2.1 billion in 2022. The global market is expected to expand at an average CAGR of 8.5% and reach US$ 4.7 billion by 2032.

Sensor Patches Market Development: The global sensor patches market reaches a valuation of US$ 3.1 billion in 2023, with a projected CAGR of 39.5% from 2023 to 2033. By 2033, the market is anticipated to reach US$ 85.8 billion. 

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:           

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube